Temozolomide for recurrent meningiomas: a case-report with unexpected clinical and radiological response

J Neurooncol. 2016 Mar;127(1):201-3. doi: 10.1007/s11060-015-2016-6. Epub 2015 Nov 27.

Authors

Alessia Pellerino¹, Riccardo Soffietti², Roberta Rudà²

Affiliations

¹ Department of Neuro-Oncology, University and City of Health and Science, Via Cherasco 15, 10126, Turin, Italy. alessia.pellerino@alice.it.
² Department of Neuro-Oncology, University and City of Health and Science, Via Cherasco 15, 10126, Turin, Italy.

PMID: 26614515
DOI: 10.1007/s11060-015-2016-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Alkylating / therapeutic use*
Dacarbazine / analogs & derivatives*
Dacarbazine / therapeutic use
Humans
Magnetic Resonance Imaging
Male
Meningeal Neoplasms / drug therapy*
Meningeal Neoplasms / pathology
Meningioma / drug therapy*
Meningioma / pathology
Middle Aged
Neoplasm Recurrence, Local / drug therapy*
Neoplasm Recurrence, Local / pathology
Prognosis
Temozolomide

Substances

Antineoplastic Agents, Alkylating
Dacarbazine
Temozolomide